Parkinson’s discovery opens door to new targeted therapies
Around a million Americans are living with Parkinson’s disease, the neurological condition that greatly, and most often progressively, affects the dopamine-producing powerhouse area of the brain, the substantia nigra. While there is no cure, medication is generally aimed at substituting or boosting dopamine, which can help lessen the movement-impairment that comes with the debilitating disease.
Tags: Northwestern University, Parkinson’s Disease, Genetics, Parkinson, Neurological, Cellular, Brain
Continue reading Parkinson’s discovery opens door to new targeted therapies